Robin Emsley, MD
- 7Articles
- 31.4KReads
- 2004–2018Active
- 39Collaborators
- 303Citations
About
Robin Emsley, MD, has published extensively on topics including major depressive disorder, schizophrenia and schizoaffective disorders, neurology, and metabolic disorders. The research covers clinical trials on antidepressants such as tianeptine and agomelatine, as well as studies on antipsychotic treatment effects, relapse prevention, and symptom patterns in first-episode psychosis. Emsley’s work also addresses metabolic changes associated with antipsychotic medications and the treatment of tardive dyskinesia. The author’s publications span from 2004 to 2018 and include collaborations with several frequent co-authors.
Publications
Schizophrenia Relapse After Antipsychotic Discontinuation
June 19, 2018
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
